Sonendo Inc (OTCPK:SONX)

$ 1.3525 -0.1975 (-12.74%) Market Cap: 565,000.00 Enterprise Value: 2.70 Mil PE Ratio: 0 PB Ratio: 0.05 GF Score: 36/100

Q2 2024 Sonendo Inc Earnings Call Transcript
Aug 07, 2024

$15.26 (+3.39%)

Earnings
Q1 2024 Sonendo Inc Earnings Call Transcript
May 08, 2024

$18 (-11.76%)

Earnings
Q4 2023 Sonendo Inc Earnings Call Transcript
Mar 11, 2024

$34

Earnings
Q3 2023 Sonendo Inc Earnings Call Transcript
Nov 08, 2023

$56 (+3.70%)

Earnings
Q2 2023 Sonendo Inc Earnings Call Transcript
Aug 09, 2023

$250 (+3.31%)

Earnings
Sonendo Inc at Goldman Sachs Healthcare Conference Transcript
Jun 12, 2023
Sonendo Inc at Stifel Jaws & Paws Conference (Virtual) Transcript
Jun 01, 2023
Q1 2023 Sonendo Inc Earnings Call Transcript
May 09, 2023

$236 (-6.35%)

Earnings
Q4 2022 Sonendo Inc Earnings Call Transcript
Mar 08, 2023

$398 (-9.55%)

Earnings
Q3 2022 Sonendo Inc Earnings Call Transcript
Nov 09, 2022

$388 (+12.14%)

Earnings
Sonendo Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2022
Q2 2022 Sonendo Inc Earnings Call Transcript
Aug 10, 2022

$304 (+6.29%)

Earnings
Sonendo Inc at Bank of America Healthcare Conference Transcript
May 11, 2022
Q1 2022 Sonendo Inc Earnings Call Transcript
May 10, 2022

$540 (+3.45%)

Earnings

Sonendo Inc at Stifel Jaws & Paws Conference (Virtual) Transcript

Jun 01, 2023 / 01:10PM GMT

Release Date Price: $244 (-3.94%)

Transcript

Jon Block

Stifel Financial Corp. - Analyst

Good morning. We're going to continue to move forward. I'm Jon Block with Stifel, and we're excited to be joined by Sonendo. Bjarne Bergheim, President and CEO; Mike Watts, down all the way on the right there, Chief Financial Officer; and Michael Smith, Chief Commercial Officer.

Sonendo is disrupting the endodontic industry with their GentleWave System, offering a novel approach to root canal therapy. A lot of talk about. Maybe I'll just start, Bjarne. Continue to hear concerns about the consumer in dentistry. But when we hear about concerns, it's more specific to clear aligners, implants, more discretionary types of procedures. The market that you're addressing, root canals, are less discretionary, obviously.

Questions & Answers

Jon Block

Stifel Financial Corp. - Analyst

So maybe just talk to us about what you're seeing out there, how PIs are currently trending in the marketplace.

Bjarne Bergheim

Sonendo, Inc. - President & CEO

Well, in general,

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.